Want to join the conversation?
$UHS expects FY16 adjusted net income attributable to the company of $7.12-7.58 per diluted share, up 4-10% versus FY15, and net revenue of $9.75-9.85Bil, up 8-9%. In FY16, $UHS expects about $5MM EHR incentive income and about $36MM EHR-related D&A expense, resulting in a net unfavorable after-tax impact of about $17MM or $0.17 per diluted share.
Does anyone feel $SBUX CEO Schultz stepping down could prove a disaster for the company?
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.